IT Maintenance is being performed on Tuesday 23 April between 6.00am and 8.30am. This may affect your ability to access your Member Portal, the Fees List and the Medical Journal of Australia during this time. All endeavours are being made to limit the impact. If you experience login issues during this time, please try again in 15mins.

Submission

AMA submission on the Transparency Bill regulating pharmaceutical company and doctor relationships

Published 1 September 2013

The AMA has made the following submission to the Senate Inquiry into the Therapeutic Goods Amendment (Pharmaceutical Transparency) Bill 2013.

AMA submission on the Transparency Bill regulating pharmaceutical company and doctor relationships

Related Download

Related topics

More across the AMA

Become an AMA member